FDA High-Risk Medical Device Recall Pilot Expedites Alerts

The FDA medical device center is announcing a pilot program aimed at expediting public and healthcare provider notifications about potentially high-risk medical device recalls.

How Will FDA Early Alerts Improve High-Risk Medical Device Recall Notifications?

The initiative focuses on providing early alerts about device removals or corrections that pose significant safety risks, particularly in the fields of cardiovascular, gastrorenal, general hospital, obstetrics and gynecology, and urology. This effort is part of the CDRH’s (Center for Devices and Radiological Health) ongoing commitment to minimize the delay between the FDA’s awareness of a potential high-risk issue and public notification. The pilot does not alter existing recall processes for other device areas.

The move, which increases transparency, comes in the wake of high-profile safety issues with medical devices and criticism of the FDA’s recall system. The CDRH has pledged to reduce the time lag in public recall awareness, responding to patient input and a 2021 advisory committee meeting. The importance of product and patient safety is underscored by the fact that recalls can be associated with deaths and serious injuries. As of Friday 22nd November, the FDA has issued 93 Class I medical device recall notices.

You can read more about this update here or here.

_____________________________________________

The FDA pilot program represents a significant step toward enhancing transparency and protecting public health. If you have questions about the FDA pilot program providing public and healthcare providers notification about high-risk medical device recalls or need assistance ensuring compliance, contact us today for expert guidance.

Learn how MedEnvoy can assist you:

• • • US FDA Agent
    • US FDA 510(k) Compilation and Consulting
    • FDA Premarket Approval PMA Consulting